Uploaded May 2022 | Updated September 2026, 8 hours ago
Recording of briefing on state Public Medications policy - May 16, 2022
Description: A new vista is opening up in the fight for more affordable medication: Publicly-owned pharmaceutical enterprises, created by states to develop, manufacture, and distribute medication in the public interest. California is taking steps to produce its own low-cost insulin — and Washington’s state legislature recently passed legislation to empower the state to partner with other states or organizations to produce, distribute, and purchase generic prescription drugs. Learn from experts and advocates on the front lines of Public Meds about how your state can break Big Pharma monopolies, address shortages, and lower prices for your residents.
Speakers:
0:00 Welcome — Pete Davis (Director, Democracy Policy Network)
4:14 Overview of the problem with monopolistic private medicine production — Madi Johnson (WA Chapter Leader, T1International)
12:15 Overview of the public medications model - Dana Brown (Director of Health and Economy, Democracy Collaborative)
18:40 California's SB852 and SB838 - Senator Richard Pan (CA)
26:28 Washington's SB5203 - Senator Karen Keiser (WA)
32:33 Maine's SP574 - Senator Trey Stewart (ME) + puppies
40:15 California Implementation - David Toppelberg (Project Manager, CalRx)
47:05 Washington Implementation - Donna Sullivan (Chief Pharmacy Officer, WA HCA)
50:27 Question and Answer
Recording of briefing on state Public Medications policy - May 16, 2022
Description: A new vista is opening up in the fight for more affordable medication: Publicly-owned pharmaceutical enterprises, created by states to develop, manufacture, and distribute medication in the public interest. California is taking steps to produce its own low-cost insulin — and Washington’s state legislature recently passed legislation to empower the state to partner with other states or organizations to produce, distribute, and purchase generic prescription drugs. Learn from experts and advocates on the front lines of Public Meds about how your state can break Big Pharma monopolies, address shortages, and lower prices for your residents.
Speakers:
0:00 Welcome — Pete Davis (Director, Democracy Policy Network)
4:14 Overview of the problem with monopolistic private medicine production — Madi Johnson (WA Chapter Leader, T1International)
12:15 Overview of the public medications model - Dana Brown (Director of Health and Economy, Democracy Collaborative)
18:40 California's SB852 and SB838 - Senator Richard Pan (CA)
26:28 Washington's SB5203 - Senator Karen Keiser (WA)
32:33 Maine's SP574 - Senator Trey Stewart (ME) + puppies
40:15 California Implementation - David Toppelberg (Project Manager, CalRx)
47:05 Washington Implementation - Donna Sullivan (Chief Pharmacy Officer, WA HCA)
50:27 Question and Answer
